Assembly Biosciences, Inc. (ASMB)
33.19
-0.82
(-2.41%)
USD |
NASDAQ |
Jan 02, 12:35
Assembly Biosciences Research and Development Expense (TTM): 61.75M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Gilead Sciences, Inc. | 5.734B |
| CorMedix, Inc. | 12.46M |
| Supernus Pharmaceuticals, Inc. | 104.86M |
| NovaBay Pharmaceuticals, Inc. | -- |
| Palatin Technologies, Inc. | 11.68M |